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Background: Lumbar radicular pain is categorized as a type of neuropathic pain, but its pathophysiological mechanisms
are not fully understood. The substantia gelatinosa (SG) in the spinal cord dorsal horn receives primary afferent inputs and
is considered to be a therapeutic target for treating neuropathic pain. In vivo patch-clamp recording is a useful procedure
for analyzing the functional properties of synaptic transmission in SG neurons. Transient receptor potential ankyrin 1
(TRPA1) has been widely identified in the central and peripheral nervous systems, such as in the peripheral nociceptor,
dorsal root ganglion, and spinal cord dorsal horn and is involved in synaptic transmission of pain. However, its functional
role and mechanism of pain transmission in the spinal cord dorsal horn are not well understood. The purpose of this
study was to use in vivo patch-clamp analysis to examine changes in the excitatory synaptic transmission of SG neurons
treated with TRPA1 antagonist and to clarify the potential role of TRPA1 in the rat spinal cord dorsal horn.
Results: The rats with root constriction (RC) showed mechanical hypersensitivity, hyperalgesia, and thermal hyperalgesia.
In addition, pin pricks elicited pain-related behavior even in the sham and naïve rats. These pain-related behaviors were
significantly attenuated by intrathecal injection of a TRPA1 antagonist. The degrees of intrathecal injection efficacy were
equivalent among the 3 groups (RC, sham, and naïve groups). In an electrophysiological study, the frequencies
and amplitudes of excitatory postsynaptic currents (EPSCs) were significantly increased in the RC rats compared
with those in the sham and naïve rats. Spontaneous EPSCs and evoked-EPSCs by non-noxious and noxious stimuli
were significantly decreased by TRPA1 antagonist. As in the behavioral study, there were no statistically significant
differences among the 3 groups.
Conclusion: These data showed that the TRPA1 antagonist had an inhibitory effect on mechanical hypersensitivity
and hyperalgesia as well as on physiological pain transmission in the spinal cord dorsal horn. This suggests that
TRPA1 is consistently involved in excitatory synaptic transmission even in the physiological state and has a role in
coordinating pain transmission.
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Lumbar radicular pain is one of the most common
symptoms caused by lumbar disc herniation or lumbar
spinal canal stenosis. Radicular pain has characteristic
symptoms, such as spontaneous pain, allodynia, and
hyperalgesia, which are felt in the gluteal region, thigh,
leg, and foot. In addition, radicular pain is difficult to
relieve and develops into chronic neuropathic pain. Re-
cently, there have been many investigations of neuropathic
pain [1]. The substantia gelatinosa (SG) in the spinal cord
dorsal horn receives primary afferent inputs, which pre-
dominantly convey nociceptive sensations. Nociceptive in-
formation is integrated and modified in SG. Therefore, SG
may be a therapeutic target for treating neuropathic pain.
In vivo patch-clamp recording [2,3] is an electrophysio-
logical procedure used to observe the tiny membrane cur-
rents and voltages of SG neurons. It is a useful procedure
for analysis of the functional properties of synaptic trans-
mission in response to naturally applied non-noxious and
noxious stimuli because diverse synaptic connectivity is
preserved. We previously used in vivo patch-clamp analysis
and showed that nerve root injury proximal to the dorsal
root ganglion (DRG) led to characteristic excitatory syn-
aptic transmission in SG neurons and changed sensory
processing in SG neurons [4]. The changes in synaptic
transmission led to spontaneous pain, mechanical allody-
nia, and hyperalgesia contributing to the pathogenesis of
radicular pain.
Because transient receptor potential vanilloid 1 (TRPV1),
which is a capsaicin receptor, was reported to be involved
in pain transmission [5], an interest in temperature-
sensitive transient receptor potential (TRP) channels has
increased significantly [6,7]. Transient receptor potential
ankyrin 1 (TRPA1) is a calcium-permeable non-selective
cation channel [8,9]. TRPA1 functions as a polymodal noci-
ceptor and can be activated in vitro by mechanical, osmotic,
thermal, and chemical stimuli [9-13]. TRPA1 has been
widely identified in the central and peripheral nervous sys-
tems, such as in the peripheral nociceptor, DRG, and spinal
cord dorsal horn [9,14-16]. Numerous studies have shown
that TRPA1 is involved in mechanical hyperalgesia, allody-
nia, and pain hypersensitivity in the peripheral and central
mechanisms [17-20]. TRPA1 was reported to involve
excitatory synaptic transmission of glutamic acid from the
central terminal of primary afferent fibers. Expression of
TRPA1 is upregulated in the spinal cord dorsal horn and
nociceptors by spinal nerve injury [18,21]. Therefore, it is
likely that inhibition of TRPA1 in the spinal cord dorsal
horn decreases the excitability of SG neurons and that pain
transmission or hyperalgesia in the neuropathic pain is con-
sequently attenuated. Some reports have stated that TRPA1
agonists act at both the pre- and postsynaptic terminals
[16,19,20]. On the other hand, others have stated that
TRPA1 antagonists act only at pre-synaptic terminals in thespinal cord dorsal horn [22]. The functional role of TRPA1
regarding the mechanism of pain transmission is not well
understood in the spinal cord dorsal horn.
The purpose of this study was to examine changes in
the excitatory synaptic transmission of SG neurons
treated with a TRPA1 antagonist and to determine the
role of TRPA1 in physiological or neuropathic pain
transmission in the spinal cord dorsal horn. We per-
formed a behavioral study that used a pin-prick test
[23], which provokes pain in the physiological state
(non-hypersensitivity state), and performed an electro-
physiological study that used in vivo patch-clamp recording
[2,3], which can observe the electrophysiological changes in
SG neurons caused by physiological stimuli and drugs.
Results
Radicular pain
In the behavioral study, the rats with root constriction
(RC) showed mechanical hypersensitivity, mechanical
hyperalgesia, and thermal hyperalgesia. Figure 1A shows
the time course of the response rate to non-noxious
mechanical stimuli using a 3.2-g von Frey filament in
the RC group (n = 15), the sham group (n = 15), and the
naïve group (n = 15). The response rate in the RC group
were significantly increased from 3 days after the nerve
root injury and thereafter. Those in the sham group and
naïve group were not increased. Similarly, the differential
score for noxious thermal stimuli was significantly higher
in the RC group than in the sham and naïve groups
(Figure 1B). In the physiological state (sham and naïve
groups), pin prick elicited pain-related behavior. The
response rate for noxious pain stimuli using the pin-prick
test was significantly higher in the RC group than in the
sham and naïve groups (Figure 1C).
Spontaneous pain evaluated on a numerical scale was
significantly higher in the RC group than in the sham
group and naïve group at 14 days after nerve root injury
(Figure 1D). In the sham group and naïve group, all rats
showed normal positioning of the hind paw (n = 15,
scale = 0, each group). In the RC group, all rats exhibited
abnormal positioning of the lesioned hind paws, and the
median scale number was 2.5.
Effects of a TRPA1 antagonist on pain-related behavior
Intrathecal injection of HC-030031, a TRPA1 antagonist,
at a dose of 10 μg significantly decreased the response rate
to the von Frey test and pin-prick test and decreased the
spontaneous pain scale number. The response rate elicited
by the von Frey filament was significantly decreased when
mechanical hypersensitivity was assessed between 5 and
60 minutes after HC-030031 treatment in the RC group
(Figure 2A). On the other hand, no changes were observed
in the sham and naïve groups. The response rates elicited
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Figure 1 Time course for mechanical hypersensitivity, thermal hyperalgesia, mechanical hyperalgesia, and spontaneous pain. (A) A 3.2-g von
Frey filament was used to evaluate mechanical hypersensitivity. Root constriction (RC) rats (black circles) showed mechanical hypersensitivity from day 3–14
after the nerve root injury compared with sham rats (white triangles) and naïve rats (white squares). (B) The differential score was used to evaluate thermal
hyperalgesia. The differential score was significantly higher in the RC rats than in the sham rats and naïve rats from day 3 thereafter. (C) The pin-prick test
was used to evaluate mechanical hyperalgesia. RC rats showed significantly higher withdrawal responses than the others from day 3 thereafter. In addition,
the injured side in the RC rats (black circles), sham rats, and naïve rats and the noninjured side in the RC rats (white circles) also showed
withdrawal responses. Error bars denote the standard error of the mean. *P < 0.05 compared with sham and naïve rats; one-way factorial
measures of analysis of variance followed by the Tukey–Kramer test. (D) The numerical scale (see text) at day 14 was used to evaluate the
degree of spontaneous pain-related behavior. All RC rats showed abnormal positioning of the lesioned hind paw, whereas all sham rats and
naïve rats showed normal positioning of the hind paw. *P < 0.05 (Mann–Whitney U test).
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5 and 60 minutes after HC-030031 treatment (Figure 2B).
There were no significant differences in intrathecal injec-
tion efficacy against responses to the pin-prick test among
the 3 groups (Figure 2C). The spontaneous pain scale num-
ber in the RC group was also significantly decreased at
30 minutes after HC-030031 treatment (Figure 2D).
In vivo patch-clamp recording at baseline
A total of 175 SG neurons were recorded at the L5
segmental level of the spinal cord: 63 SG neurons in the
RC group, 47 SG neurons in the sham group, and 65 SG
neurons in the naïve group. No significant differences in
the mean depths of the recording sites were observed
from the surface of the spinal cord, resting membranepotential, or input resistance of the SG neurons among
the 3 groups (data not shown). The recordings were usu-
ally obtained from SG neurons in a stable condition for
10–30 minutes, and stable recordings were maintained
in several neurons for more than 5 hours.
Excitatory postsynaptic currents in SG neurons after
nerve root injury
All SG neurons exhibited spontaneous excitatory post-
synaptic currents (EPSCs), and the SG neurons that had
a receptive field produced large-amplitude (>50 pA) bar-
rages of EPSCs in response to air-puff or pinch stimuli
to the skin of the gluteal region or hind paw at a holding
potential (VH) of −70 mV. The mean frequencies and
























































































Figure 2 Effects of HC-030031 on root constriction (RC)-induced mechanical hypersensitivity, hyperalgesia, and spontaneous pain.
The time course for mechanical hypersensitivity and mechanical hyperalgesia in the RC rats, sham rats, and naïve rats after HC-030031 treatment
(10 μg, intrathecally). (A) The response rate evaluated by a 3.2-g von Frey test was significantly decreased by HC-030031 treatment in the RC rats
but did not change in the sham rats and naïve rats. Intrathecal injection of vehicle had no effect in any of the groups. (B) The response rate
evaluated by pin-prick test was significantly decreased by HC-030031 treatment in the RC rats, sham rats, and naïve rats. Intrathecal injection of
vehicle also had no effect in any of the groups. *P < 0.05 compared with RC + vehicle, +/#P < 0.05 compared with naïve + vehicle; one-way factorial
measures of analysis of variance followed by Tukey–Kramer test. (C) Intrathecal injection efficacy was calculated by dividing the response
rate after HC-030031 treatment by the response rate at baseline. There was no statistical difference among the RC rats, sham rats, and naïve
rats. (D) The degree of spontaneous pain-related behavior was significantly decreased after HC-030031 treatment. Pre-From = before drug
injection. *P < 0.05 (Mann–Whitney U test).
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and 23.2 ± 0.8 pA, respectively; n = 63) than in the sham
group (8.0 ± 0.8 Hz and 20.5 ± 0.7 pA, respectively; n =
47) and naïve group (8.0 ± 0.6 Hz and 19.2 ± 0.6 pA,
respectively; n = 65) (P < 0.05) (Figure 3).
Effects of a TRPA1 antagonist on EPSCs
HC-030031 decreased the frequencies and amplitudes in
10 of 11 recorded SG neurons in the RC group, 11 of 12
in the sham group, and 10 of 11 in the naïve group. In
all 3 groups, the frequencies and amplitudes of both the
spontaneous EPSCs and evoked EPSCs were significantly
decreased after HC-030031 treatment. In the root constric-
tion group, the frequency and amplitude of spontaneousEPSCs were decreased (75.0 ± 4.8% of the control frequency
and 83.9 ± 3.6% of the control amplitude) within 30 seconds
and those of evoked EPSC were also decreased (79.9 ± 5.0%
of the control frequency and 84.6 ± 1.9% of the control
amplitude by air-puff stimuli, 75.9 ± 4.8% of the control fre-
quency and 83.1 ± 2.8% of the control amplitude by pinch
stimuli). In the sham group, the frequency and amplitude
of spontaneous EPSCs were decreased (75.6 ± 4.2% of the
control frequency and 91.1 ± 1.9% of the control amplitude)
and those of evoked EPSCs were also decreased (81.6 ±
3.4% of the control frequency and 78.9 ± 2.9% of the control
amplitude by air-puff stimuli, 82.4 ± 2.2% of the control
frequency and 79.5 ± 3.6% of the control amplitude by
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Figure 3 (See legend on next page.)
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Figure 3 HC-030031 decreases the frequencies and amplitudes of spontaneous EPSCs. Representative traces from in vivo patch-clamp recording
show the spontaneous EPSCs in the absence (left) or presence (right) of HC-030031 (100 μM) of spontaneous EPSCs (A), air-evoked EPSCs (B), and
pinch-evoked EPSCs (C). The frequencies and amplitudes of spontaneous EPSCs were significantly higher in the root constriction (RC) rats than in the









































Figure 4 Changes of EPSCs in SG neurons after HC-030031
treatment. The relative frequencies (A) and amplitudes (B) of
spontaneous EPSCs and evoked-EPSCs by air-puff or pinch stimuli
were significantly decreased after HC-030031 treatment (100 μM) in
the root constriction (RC), sham, and naïve groups. There were no
significant differences in the relative frequencies and amplitudes
among the 3 groups. *P < 0.05 compared with the frequencies and
amplitudes before HC-030031 treatment in the respective groups
(Student’s paired t test).
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4.8% of the control frequency and 91.4 ± 1.2% of the control
amplitude) and those of evoked EPSCs were also decreased
(87.2 ± 1.8% of the control frequency and 82.2 ± 2.9% of the
control amplitude by air-puff stimuli, 83.8 ± 3.1% of the
control frequency and 81.2 ± 3.8% of the control amplitude
by pinch stimuli). There were no statistically signifi-
cant differences in the relative frequencies and relative
amplitudes of the spontaneous EPSCs, EPSCs evoked
by air-puff stimuli, and EPSCs evoked by pinch stimuli
among the 3 groups (Figure 4).
Discussion
In the present study, to assess the functional role of
TRPA1 in the spinal cord dorsal horn, we evaluated
behavioral changes after intrathecal injection of a select-
ive TRPA1 antagonist and electrophysiological changes
assessed by in vivo patch-clamp recording. The following
main results were found: (1) A TRPA1 antagonist atten-
uated pain-related behavior elicited by noxious pain
stimuli in the physiological state. (2) A TRPA1 antagon-
ist attenuated mechanical hypersensitivity and hyper-
algesia caused by non-noxious and noxious stimuli and
attenuated spontaneous pain-related behavior in the
neuropathic pain state. (3) A TRPA1 antagonist reduced
the frequencies and amplitudes of spontaneous EPSCs in
approximately 90% of SG neurons in the spinal cord
dorsal horn.
The role of TRPA1 in excitatory synaptic transmission
elicited by non-noxious and noxious stimuli
Some studies have shown that mechanical hypersensitivity
against the von Frey filament was manifested in inflamma-
tory and chemical pain due to injection of Complete
Freund’s Adjuvant, formalin, and mustard oil to the hind
paw. The mechanical hypersensitivity was inhibited by
intrathecal or intraplantar injection of a TRPA1 antagonist
[24-27]. In addition, other studies have shown that mechan-
ical hypersensitivity in the neuropathic pain model of
chronic constriction injury or spinal nerve ligation (SNL)
was inhibited by intrathecal injection of a TRPA1 antagon-
ist [27]. There have been few behavioral studies on the in-
volvement of TRPA1 in noxious stimuli in the physiological
state. In an electrophysiological study, McGaraughty et al.
reported that a TRPA1 antagonist decreased firing to pinch
stimuli but did not decrease firing to tactile stimuli in spinal
wide dynamic range neurons [28]. Some reports have used
thermal stimuli for evaluating noxious stimuli in non-neuropathic pain models [24,26,27,29]. Because TRPA1 is
activated by cold stimuli <17°C, the evaluation of TRPA1
regarding pain transmission may not have been accurate.
We used a pin-prick test [23], in which pain-related behav-
ior could be observed in not only the neuropathic pain state
but also the physiological state to evaluate pain-related
behavior after exposure to noxious pain stimuli.
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related behavior elicited by non-noxious and noxious
stimuli in the RC group, sham group, and naïve group,
but there were no significant differences among the 3
groups. Similarly, the frequencies and amplitudes of
EPSCs evoked by pinch stimuli obtained from in vivo
patch-clamp recording were decreased by a TRPA1
antagonist in all 3 groups, and the degree of decrease
among the 3 groups did not significantly differ. There-
fore, it is suggested that TRPA1 is involved in physio-
logical pain transmission in the spinal cord dorsal horn
and is not particularly involved in neuropathic pain. In
addition, the decreases in the frequencies and ampli-
tudes of the spontaneous EPSCs caused by the TRPA1
antagonist indicate that TRPA1 is always active in the
spinal cord dorsal horn at a constant rate without any
stimuli.
It is well known that the voltage-dependent calcium
channel in the central end of primary afferent fibers is
activated when action potential from peripheral nocicep-
tors is reached. Both TRPA1 and the voltage-dependent
calcium channel cause calcium to flow into a cell and
release the neurotransmitter glutamic acid from synaptic
vesicles to the synaptic cleft. Thus, TRPA1 may consist-
ently cause excitability of SG neurons and pain transmis-
sion in the spinal cord dorsal horn.
The role of TRPA1 in the spinal cord dorsal horn in
neuropathic pain
Intrathecal injection of a TRPA1 antagonist significantly
affected pain-related behavior in the RC group and nor-
mal pain-related behavior in the sham group and naïve
group. However, there were no significant differences in
the behavioral study and electrophysiological study re-
sults among the 3 groups. Thus, TRPA1 appeared to be
active in the neuropathic pain state and physiological
state. Obata et al. reported that expression of TRPA1
was downregulated in the L5 segment and upregulated
in the L4 segment when only the L5 nerve root was cut
distal to the DRG in SNL model rats [18]. In addition,
Kim et al. reported that dorsal rhizotomy caused down-
regulation of TRPA1 expression at the same segment in
the spinal cord dorsal horn [16]. When inflammatory or
nerve injury occurred distal to DRG, nerve growth factor
increased in inflamed or injured tissue and was trans-
ported to DRG; subsequently, TRPA1 was produced in
the DRG and transported to peripheral nociceptors
and the central end of primary afferent fibers [18,30,31].
Thus, when the spinal cord and DRG were unconnected
because of a dorsal rhizotomy, the expression of TRPA1
decreased in the central end of primary afferent fibers
[16,18]. We used radicular pain models in which nerve
roots were injured proximal to DRG. No previous study
has evaluated the expression of TRPA1 in the spinalcord dorsal horn in the same pain model. In previous
slice patch-clamp recording studies, 30%–60% of re-
corded cells were affected by a TRPA1 agonist [19,20].
On the other hand, in the present study, we observed
synaptic transmission of SG neurons by in vivo patch-
clamp recording, and approximately 90% of the recorded
cells were affected by a TRPA1 antagonist. Because the
membrane current of SG neurons was recorded under
in vivo conditions, abundant synapses were completely
preserved, and the TRPA1 antagonist affected many cells,
in contrast to the methods used in the previous studies.
Degeneration occurs in primary afferents of the L5 nerve
root after L5 nerve root injury, which results in a decrease
in the number of synapses between primary afferents and
spinal cord dorsal horn neurons [32]. This could explain
why the effect of the TRPA1 antagonist was not increased
after nerve root constriction proximal to DRG. After nerve
root injury, TRPA1 production increased in DRG, whereas
the number of synapses was decreased because of degener-
ation. Therefore, the degree of TRPA1 expression may not
have changed in the spinal cord dorsal horn. There is
another possibility that inactivated TRPA1 increase after
nerve root constriction. Immunostaining of TRPA1 expres-
sion may be required in further study.
Possibility of TRPA1 as a therapeutic target for pain
Bautista et al. reported that bradykinin activated TRPA1
by phospholipase C activation and produced peripheral
sensitization in which thermal hyperalgesia developed.
The authors expected to observed clinical effects from
use of TRPA1 antagonists [29].
TRPA1 is activated by mechanical, thermal, and chem-
ical stimuli [10-12,29] and expressed in the auditory or-
gans, respiratory tract, and gastrointestinal tract [33-36].
When TRPA1 is inhibited, the side effects in each of
these organs become a major problem. However, it has
recently been reported that auditory difficulties or de-
creases in body temperature caused by local or systemic
administration of TRPA1 antagonists did not occur
[29,37]. It is still controversial whether inactivation of
TRPA1 results in decreasing response to cold stimuli [7].
The present study showed that a TRPA1 antagonist sup-
pressed transmission of physiological pain and neuropathic
pain in the spinal dorsal horn. These findings indicate that
TRPA1 antagonists can be used as universal analgesic
drugs. On the other hand, the TRPA1 antagonist also
decreased EPSCs evoked by air-puff stimuli in naïve rats.
Therefore, it is possible that transmission of normal tactile
stimuli or warning signals to the body may be inhibited as a
side effect.
Conclusion
In the present study, we found that a TRPA1 antagonist
had an inhibitory effect on mechanical hypersensitivity
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the physiological state in the spinal cord dorsal horn.
The results suggest that TRPA1 is consistently associ-
ated with excitability of SG neurons in the spinal cord
dorsal horn and that it may have an important role in
coordination of pain transmission.
Methods
Experimental animals
All experimental procedures were approved by the Animal
Care and Use Committee of the Sapporo Medical
University School of Medicine, Sapporo, Japan. We
used a total of 220 male Sprague–Dawley rats aged
5 weeks and weighing 140–160 g at the beginning of
the experiments. All efforts were made to minimize
animal suffering and the number of animals used, and
the experiments followed the ethical guidelines of the
International Association for the Study of Pain [38].
Surgical procedures for producing the radicular pain model
The animals were randomly divided into 3 experimental
groups: the RC group, sham operation group, and naïve
group. The surgical procedures have been described in
detail previously [39]. In brief, after the rats were anes-
thetized with intraperitoneal sodium pentobarbital
(50 mg/kg), they were placed in the prone position, and
a midline dorsal incision was made in the lower back to
expose the laminas between the L4 and S1 vertebrae.
The paraspinal muscles were retracted to expose the
right L5–L6 facet joint. A right L5 hemilaminectomy
and an L5–L6 partial facetectomy were performed. In
the RC group, the right L5 spinal root was carefully ex-
posed and tightly ligated extradurally by using 8–0 nylon
sutures proximal to DRG. The subcutaneous tissue and
skin were then closed by using 4–0 nylon sutures. In the
RC group, 78 rats (n = 15 for the behavioral studies, n =
63 for the electrophysiological studies, as described
below) and in the sham operation group, 62 rats (n = 15
for the behavioral studies, n = 47 for the electrophysio-
logical studies, as described below) underwent the surgical
procedure as described above without nerve root constric-
tion. In the naïve group, 80 rats (n = 15 for the behavioral
studies, n = 65 for the electrophysiological studies, as
described below) were used with any surgical procedures.
Evaluation of mechanical hypersensitivity
To assess the mechanical withdrawal response, the rats
were placed in a Plexiglas chamber (IITC Life Science
Inc., Woodland Hills, CA, USA, measuring 18 × 25 × 18 cm
above a wire mesh floor, which allowed full access to the
hind paw, and were acclimatized to the environment for at
least 20 minutes before the test. A 3.2-g von Frey filament
(Semmes–Weinstein Monofilaments, North Coast Medical
Inc., San Jose, CA, USA) was used to produce mechanicaltactile stimuli, which were applied to the middle area
between the foot pads on the plantar surface of the right
(constriction side) and left (contralateral side) hind paws.
Each hind paw was probed consecutively by 10 stimulations
alternating between the right and left for each set. This was
repeated thrice at intervals of at least 10 minutes [39,40].
Mechanical sensitivity was evaluated as the response rate of
withdrawal responses. Visible lifting of the stimulated hind
limb was considered to be a withdrawal response. This
procedure was performed 1 day before and 3, 5, 7, 10 and
14 days after surgery.
Evaluation of physiological pain and mechanical
hyperalgesia
Followed by the von Frey test, a pin-prick test was used to
evaluate mechanical nociception and hyperalgesia [23]. A
26-gauge needle was used to apply noxious pain stimuli in
the same manner as used for the von Frey filament. The
needle was pressed up to 0.5 g to prevent tissue damage.
The response rate of each rat were expressed at the injured
side and noninjured side, respectively.
Evaluation of thermal hyperalgesia
To assess the thermal withdrawal response, the rats were
placed in a Plexiglas chamber on a glass platform and
allowed to acclimatize for at least 20 minutes before the
test. The thermal withdrawal response was measured as
the latency of hind paw withdrawals elicited by a radiant
heat source (Tail Flick Analgesia Meter, IITC Life Sci-
ence Inc.), which was moved beneath the portion of the
hind paw that was flush against the glass, and thermal
stimulation was delivered to that site. Thermal hyper-
algesia was evaluated as thermal withdrawal latency,
which was defined as the time from the onset of radiant
heat to the withdrawal of the tested foot. A cutoff time
of 10 seconds was set to prevent tissue damage. Each
hind paw was tested 5 times with at least 5-minute inter-
vals, alternating between the right and left. The mean
withdrawal latency was calculated from the last 4 mea-
surements. Consequently, the thermal withdrawal la-
tency of each rat was defined as the differential score,
which was calculated by subtracting the withdrawal
latency of the injured side from that of the noninjured
side. Positive and negative scores indicated increased
and decreased sensitivity of the ipsilateral hind paw,
respectively. This test was performed after evaluating
mechanical sensitivity and hyperalgesia.
Estimation of spontaneous pain-related behaviors
To assess spontaneous pain, the rats were placed in a
Plexiglas chamber above a wire mesh floor and allowed
to acclimatize for 20 minutes before the test. Then, their
behaviors were observed for 5 minutes. A numerical
scale, as modified from a method described previously
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behavior related to spontaneous pain. The following
scale was used in this study: 0 = the paw of the operated
side was pressed normally on the floor; 1 = the paw
rested lightly on the floor; 2 = only the internal edge of
the paw was pressed on the floor; 3 = only the heel was
pressed on the floor, and the hind paw was in an
inverted position; 4 = the whole paw was elevated; 5 =
the animal licked the lesioned paw. The largest scale
number was adopted to estimate the spontaneous pain-
related behavior of the tested rat. This test was per-
formed in 14 days after surgery when mechanical hyper-
sensitivity, hyperalgesia, and thermal hyperalgesia had
fully developed. Blinding procedures were used in these
behavioral experiments.
Preparation for intrathechal drug administrations
For intrathecal drug injections, rats were anesthetized
with inhalation of isoflurane (1.5%–2%), and a polyethyl-
ene catheter (PE-10; Clay Adams, Parsippany, NJ) filled
with saline was slowly inserted through an opening in
the cisterna magna into the spinal subarachnoid space
[42-44] so that its tip lay at the level of the lumbar
enlargement of the spinal cord. This procedure was per-
formed after the behavioral evaluation in 14 days after
surgery. The external part of the catheter was tunneled
subcutaneously to exit on the top of the skull and
plugged with welting at the end of the catheter. The pos-
ition of the catheter was confirmed in the intrathecal
space at the lumbar enlargement by exposing the lumbar
spinal cord after sacrificing the animals by administering
a pentobarbital overdose at the end of the study. The
data from rats in which the catheter was in an inappro-
priate position were excluded from this study.
Effects of the selective TRPA1 antagonist on pain-related
behavior
In 15 days after surgery (within 24 hours after inserting
the catheter), we performed the von Frey test described
above for confirming that the catheter-implanted rats
showed no evident motor disturbances such as paralysis.
A selective antagonist for TRPA1, HC-030031 (Sigma, St
Louis, MO, USA), was used to evaluate the involvement
of TRPA1 in mechanical hyperalgesia. The rats were
treated with HC-030031 (10 μg/site) or with vehicle
[10% dimethylsulfoxide (DMSO) in saline] intrathecally.
The mechanical hypersensitivity and hyperalgesia were
evaluated using the von Frey test and pin-prick test de-
scribed above at different time points after HC-030031
treatment (5, 15, and 30, 60, 120, 240 and 480 minutes),
and spontaneous pain was estimated using the spontan-
eous pain scale described above at different time points
after HC-030031 treatment (30 minutes and 2 hours).
For the von Frey test and pin-prick test, the effects ofHC-030031 was assessed as the response rate. Further-
more, the effect was compared with the intrathecal
injection efficacy, which was calculated by dividing the
withdrawal frequency after HC-030031 treatment by the
baseline frequency.
Electrophysiological procedures
We performed in vivo patch-clamp recording according
to a previously described method [2,4,45-48]. The rats
were used 11–14 days after surgery when mechanical
hypersensitivity and thermal hyperalgesia had fully de-
veloped. The examiner was blinded to the 3 groups. The
rats were supplied oxygen through a nose cone under
anesthesia with intraperitoneal urethane (1.2–1.5 g/kg).
Rectal temperature was maintained at 37–38°C using a
heating pad. Laminectomy was performed from the
T13– L2 levels, after which the rats were placed in a
stereotaxic apparatus (Model ST-7, Narishige Group Co,
Tokyo, Japan), and the spinal cord was carefully exposed.
After removing the dura, the right L5 nerve root was
observed microscopically as a swollen area with a darker
color than the left L5 and right L4 nerve roots. The pia-
arachnoid membranes of the right L5 dorsal root entry
zone were cut to create a window large enough to insert
the patch electrode. The surface of the spinal cord was
irrigated with 95% O2 5% CO2-equilibrated Krebs solu-
tion (10–15 ml/min) (in mM): 117 NaCl, 3.6 KCl, 2.5
CaCl2, 1.2 MgCl2, 1.2 NaH2PO4, 11 glucose, and 25
NaHCO3 at 37.0 ± 0.5°C.
The patch electrodes were pulled from thin-walled
borosilicate glass capillaries (outer diameter of 1.5 mm,
TW150F-4, World Precision Instruments, Sarasota, FL,
USA) by using a puller (p-97, Sutter Instruments, Novato,
CA, USA) and were filled with patch-pipette solutions
composed of the following (in mM): 135 K-gluconate, 5
KCl, 0.5 CaCl2, 2 MgCl2, 5 EGTA, 5 ATP-Mg, 5 HEPES–
KOH (pH 7.2) for the EPSC recordings and current-clamp
recordings. The recording electrode (resistance range, 8–12
MΩ) was advanced at an angle of 30° into SG. After a
gigaohm seal was formed with neurons at a depth of 50–
150 μm from the surface of the spinal cord, the membrane
patch was ruptured by negative pressure, and then
the whole-cell patch-clamp recording was initiated. A
patch-clamp amplifier (Axopatch 200B, Axon Instru-
ments, Union City, CA, USA) was used to make record-
ings. In the voltage-clamp mode, the holding potentials
(VH) were −70 mV, at which glycine-mediated and
gamma-aminobutyric acid-mediated inhibitory postsyn-
aptic currents were negligible [49]. Spontaneous excita-
tory postsynaptic potentials and action potentials were
recorded in the current-clamp mode. Spontaneous and
evoked EPSCs were recorded as described later. Whole-
cell patch-clamp recordings were made from SG neu-
rons at the L5 segment of the spinal cord in the RC
Miyakawa et al. Molecular Pain 2014, 10:58 Page 10 of 11
http://www.molecularpain.com/content/10/1/58group, sham group, and naïve group. Data from neu-
rons with resting membrane potentials more positive
than −50 mV were excluded from this study.
After the electrophysiological experiment, some neu-
rons that have been injected with biocytin during the
recording were confirmed to be located in SG as described
previously [2,4,45,47]. An A/D converter (Digidata 1322A,
Axon Instruments) was used to digitize the data, which
were analyzed by using the Mini Analysis Program version
6.0.7 (Synaptosoft, Fort Lee, NJ, USA).
In the voltage-clamp mode, all SG neurons produced
large amplitude (>50 pA) barrages of EPSCs to non-
noxious or noxious stimuli, such as a paintbrush or
toothed forceps to the skin of the lumbar and pelvic
regions or the hind paw [2,4,45,46]. A paintbrush or
toothed forceps applied to the skin of the abdominal
wall, lumbar and pelvic regions, hind paw, and tail was
used to carefully determine the receptive field of a
neuron after repeated stimuli. If evoked EPSCs were not
observed during stimulation, that neuron was defined as
one with no receptive field.
After determining the receptive field, the responses to
non-noxious stimuli were assessed using a puff of air
(20 psi) through a pipette (outer diameter of 200 μm)
applied repetitively to the center of the receptive field
(duration of injection, 5 seconds) using a pico-injector
(PLI-100, Harvard Apparatus, Holliston, MA, USA), ac-
cording to a previously described method [4,47]. The
air-puff stimuli did not cause pain to the examiners. The
noxious pinch stimuli were applied with toothed forceps
that were firmly fixed on a rod. A weight (60 g) was
placed on the forceps for 5 seconds, as referred to in
previous reports [4,45,47]. SG neurons exhibited several
response profiles during air-puff or pinch stimuli in the
current-clamp mode [50,51], which have been described
in detail previously [4,47]. If the recorded neurons
responded maximally to non-noxious stimuli enough to
reach the action potential threshold, they were excluded
in the present study because they may have been located
in the lamina or deeper [4]. The air-puff and pinch stim-
uli were repeated thrice to evaluate the evoked activities
of neurons. Then mean frequencies and amplitudes of
the evoked EPSCs for each SG neuron during the stimu-
lation were calculated by the values of the 3 records.
Drug application
Drug was dissolved in Krebs solution and applied by
perfusion via a 3-way stopcock without any change in
the perfusion rate or the temperature [48]. The time ne-
cessary for the solution to flow from the stopcock to the
surface of the spinal cord was approximately 30 seconds.
The drug used in this study was HC-030031 (Waco,
Osaka, Japan). HC-030031 was first dissolved in DMSO
at 1000 times the concentrations to be used and thenwas diluted to the final concentration in Krebs solution
immediately before use.
Statistical analysis
All numerical data are expressed as means ± SEMs. One-
way factorial measures of analysis of variance followed
by the Tukey–Kramer test were used to analyze the
behavioral test data and electrophysiological data of the
3 groups. Student’s paired t test, the Mann–Whitney U
test, and the Wilcoxon signed-ranks test were used for
analysis of changes in parameters between the 2 groups.
The level of statistical significance was set to P < 0.05.
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